Both variants have been shown to result in the decrease of enzyme activity and the increase of substrate glycerol-3-phosphate, which further leads to increased Nav1.5 phosphorylation via the GPD1L-dependent pathway, significantly decreasing the sodium current density and leading to the conduction disorder (48). The gene discussed is GPD1L; the disease is conduction system disorder.